Toyobo Co., Ltd. (TYOBY) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Toyobo Co., Ltd. (TYOBY) trades at $9.80. Toyobo Co. , Ltd. is a Japanese manufacturer specializing in advanced materials, including high-performance films, functional polymers, industrial fibers, and healthcare solutions. Market cap: $865M, Sector: Basic materials.
Price as of Aug 21, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for TYOBY: TYOBY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TYOBY against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on TYOBY.
How is this calculated? →Toyobo Co., Ltd. (TYOBY) Materials & Commodity Exposure
Toyobo Co., Ltd. is a Japanese advanced materials manufacturer, established in 1882, specializing in high-performance films, functional polymers, industrial fibers, and healthcare solutions. The company leverages its diversified portfolio across packaging, electronics, automotive, and medical sectors to serve global industrial and consumer markets.
What Is the Investment Thesis for TYOBY?
Toyobo Co., Ltd. presents a diversified investment profile rooted in its extensive portfolio of advanced materials and functional products, spanning films, polymers, textiles, and healthcare. With a market capitalization of $865M and a P/E ratio of 13.74, the company demonstrates profitability with a 2.7% profit margin and a 25.7% gross margin. Its beta of 0.75 suggests lower volatility compared to the broader market. Key growth catalysts include sustained demand for high-performance films in electronics and packaging, expansion in specialized functional polymers for industrial applications, and increasing penetration in the healthcare sector through diagnostic enzymes and medical components like artificial kidney hollow fibers. The company's long-standing expertise since 1882, coupled with its R&D capabilities in advanced fibers and bio-products, positions it to capitalize on evolving material science needs. However, as an ADR trading on the OTC Other tier, investors face potential liquidity and information availability risks, necessitating close monitoring of its primary listing in Japan. The 2.30% dividend yield offers income potential.
Based on FMP financials and quantitative analysis
TYOBY Key Highlights
Market Capitalization: $0.60 billion, reflecting its valuation as a mid-sized specialty chemicals and materials company.
- Price-to-Earnings (P/E) Ratio: 13.74, indicating its earnings multiple relative to its share price.
- Profit Margin: 2.7%, demonstrating the percentage of revenue retained as net income.
- Gross Margin: 25.7%, showcasing the profitability of its core product sales before operating expenses.
- Dividend Yield: 2.30%, providing a return to shareholders from its earnings.
Who Are TYOBY's Competitors?
TYOBY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| GPRE Green Plains Inc. | $16.03 | -0.93% | $1.12B | 63 |
| ICHMF ISE Chemicals Corporation | $24.73 | +0.00% | $1.26B | 62 |
| ODC Oil-Dri Corporation of America | $92.24 | -0.31% | $1.28B | 95 |
| REX REX American Resources Corporation | $44.06 | +0.44% | $1.45B | 88 |
| ADUR Aduro Clean Technologies Inc. | $14.95 | -2.86% | $506M | 52 |
| HGRAF HydroGraph Clean Power Inc. | $4.35 | -1.58% | $1.52B | 69 |
| HUABF Huabao International Holdings Limited | $0.50 | -0.00% | $1.61B | 51 |
| HUIHY Huabao International Holdings Limited | $25.00 | +0.00% | $1.61B | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TYOBY's Key Strengths?
Diversified product portfolio across films, polymers, fibers, and bio-products.
- Long history of innovation and expertise in advanced material science since 1882.
- Presence in high-growth sectors like healthcare (diagnostics, medical components).
- Manufacturing capabilities for critical industrial and medical components.
What Are TYOBY's Weaknesses?
Exposure to raw material price fluctuations inherent in the basic materials sector.
- Potential for high R&D costs to maintain competitive edge in advanced materials.
- As an ADR on OTC Other tier, faces liquidity and information availability risks.
- Reliance on global industrial demand, susceptible to economic downturns.
What Could Drive TYOBY Stock Higher?
TYOBY catalyst: Development of new high-performance films for next-generation display technologies, potentially expanding market share in the electronics sector.
- Continued expansion in the healthcare segment through new diagnostic systems and advanced medical components, driven by global demand for health solutions.
- Successful introduction of sustainable packaging solutions, aligning with global environmental trends and increasing demand from consumer goods companies.
- Strategic investments in R&D for advanced functional polymers and fibers, leading to new applications in automotive and industrial sectors.
What Are the Key Risks for TYOBY?
Financial-distress signal — its Altman Z-Score of 1.46 sits in the distress zone (elevated bankruptcy risk).
- Volatility in raw material prices, such as petrochemicals, which could impact production costs and profit margins.
- Currency exchange rate fluctuations between the Japanese Yen and the U.S. Dollar, affecting ADR valuation and repatriated earnings.
- Intense competition in the specialty chemicals and materials industry, requiring continuous innovation to maintain market position.
- Risks associated with trading on the OTC Other tier, including lower liquidity and limited information availability for U.S. investors.
- Economic slowdowns in key industrial markets (e.g., automotive, electronics) could reduce demand for Toyobo's materials.
What Are the Growth Opportunities for TYOBY?
- Expansion in High-Performance Films for Electronics: Toyobo's expertise in PET films for liquid crystal displays and optical applications positions it to benefit from the ongoing evolution in display technologies and consumer electronics. As devices become more sophisticated and demand for high-resolution screens increases, the market for specialized optical films is expected to grow. This opportunity involves leveraging existing R&D to develop next-generation film solutions that meet stricter performance requirements for flexibility, durability, and optical clarity, potentially expanding into emerging markets for flexible electronics and advanced sensors.
- Growth in Advanced Packaging Solutions: The global packaging market, particularly for food preservation, is continuously seeking innovative materials that extend shelf life, reduce waste, and improve sustainability. Toyobo's range of PET, polyolefin, and nylon films, including heat-shrink options, directly addresses these needs. The opportunity lies in developing more eco-friendly and high-barrier packaging films that cater to evolving consumer preferences and regulatory pressures for sustainable packaging, potentially expanding its market share in the rapidly growing e-commerce food delivery sector.
- Penetration in Healthcare and Medical Devices: Toyobo's bio-products segment, which includes enzymes for diagnostics, diagnostic systems, and critical medical components like artificial kidney hollow fibers and anti-clotting materials, represents a significant growth avenue. The aging global population and increasing focus on preventative healthcare and advanced medical treatments drive demand for these specialized materials. Expanding its portfolio of diagnostic reagents and medical device components, alongside its contract manufacturing for injectables, allows Toyobo to capture a larger share of the expanding global healthcare market.
- Innovation in Functional Fibers for Automotive and Industrial Applications: The automotive industry's shift towards lighter, safer, and more fuel-efficient vehicles creates sustained demand for advanced materials like Toyobo's high-strength polyethylene and PBO fibers used in airbag fabrics and other components. Furthermore, its functional filters for automotive, indoor air quality, and anti-pollution applications address critical environmental and health concerns. Continued innovation in these areas, focusing on enhanced performance, durability, and sustainability, will allow Toyobo to capitalize on the growing market for advanced industrial textiles and filtration solutions.
- Leveraging Functional Polymers for Electronic Materials: Toyobo's functional polymers division, encompassing engineering plastics, industrial adhesives, and electronic materials, is well-positioned to benefit from advancements in various industrial sectors. The increasing complexity and miniaturization of electronic components, alongside demand for robust and reliable materials in industrial applications, create a strong market for its specialized polymers. Opportunities include developing new materials for 5G technology, advanced semiconductor packaging, and high-performance protective coatings that offer superior thermal, electrical, and mechanical properties.
What Threats Does TYOBY Face?
- Intense competition from larger multinational chemical and materials companies.
- Technological obsolescence if R&D does not keep pace with industry advancements.
- Regulatory changes impacting chemical production or material usage.
- Currency fluctuations affecting profitability of international operations and ADR value.
What Are TYOBY's Competitive Advantages?
- Diversified Product Portfolio: Broad range of advanced materials across multiple high-value sectors reduces reliance on any single market.
- Specialized Material Science Expertise: Over a century of experience in developing proprietary films, polymers, and fibers.
- Integrated R&D and Manufacturing: Ability to innovate, produce, and customize materials for specific industrial applications.
- Critical Medical Component Production: Niche market presence in essential healthcare materials like artificial kidney hollow fibers.
- Established Global Presence: Long-standing relationships and operational footprint in key industrial markets.
What Does TYOBY Do?
Toyobo Co., Ltd., founded in Osaka, Japan, in 1882, has evolved from its textile origins into a global leader in advanced materials and functional products. The company's operations are strategically diversified across five core segments: films, functional polymers, industrial materials, healthcare solutions, and textiles. In its films division, Toyobo produces a wide array of high-performance industrial films, notably PET films crucial for liquid crystal displays, optical applications, and various other industrial uses, alongside synthetic papers. For the critical packaging sector, Toyobo provides specialized PET, polyolefin, and nylon films, essential for food preservation and other packaging needs, including heat-shrink PET films. The functional polymers segment is a cornerstone of its advanced materials offerings, encompassing engineering plastics, industrial adhesives, protective coatings, photo-sensitive printing plates, acrylate polymers, and electronic materials. This division also includes rubber and coat processing capabilities and the production of intermediates vital for pharmaceutical manufacturing. Within advanced fibers and textiles, Toyobo is at the forefront of developing specialized functional fibers. These include materials integrated into airbag fabrics, high-strength polyethylene and PBO fibers, and advanced functional filters designed for diverse applications such as automotive systems, indoor air quality improvement, and anti-pollution solvent adsorption. The company also supplies fiber materials for various automobile components. Its textile offerings extend to performance fabrics for sports apparel, intimate wear, and uniforms, complemented by synthetic filaments. Toyobo also manages branded apparel lines like Munsingwear, and produces acrylic fibers (Exlan) and acrylate fibers (eks), alongside general textile trading activities. The bio-products segment underscores Toyobo's commitment to healthcare and scientific research, providing enzymes for diagnostic purposes, comprehensive diagnostic systems, and reagents for research. This division is also a key manufacturer of critical medical components, including artificial kidney hollow fibers and anti-clotting materials, as well as modules for seawater desalination. Furthermore, Toyobo leverages its expertise to operate as a contract manufacturer for injectable pharmaceutical products, demonstrating its broad capabilities across high-value industrial and healthcare applications.
What Products and Services Does TYOBY Offer?
- Manufacture high-performance industrial films, including PET films for displays and optical applications.
- Produce packaging materials such as PET, polyolefin, and nylon films for food preservation.
- Develop and supply functional polymers like engineering plastics, industrial adhesives, and electronic materials.
- Create advanced functional fibers for airbag fabrics, high-strength applications, and specialized filters.
- Offer textile products including performance fabrics for apparel and branded clothing lines.
- Provide bio-products, including enzymes for diagnostics, diagnostic systems, and medical components.
- Manufacture critical medical components such as artificial kidney hollow fibers and anti-clotting materials.
- Serve as a contract manufacturer for injectable pharmaceutical products.
How Does TYOBY Make Money?
- Develops and manufactures a diverse portfolio of advanced materials and functional products.
- Sells these specialized materials and components to industrial clients across electronics, packaging, automotive, and healthcare sectors.
- Generates revenue through direct sales of its proprietary films, polymers, fibers, and bio-products.
- Offers contract manufacturing services for injectable pharmaceuticals, leveraging its expertise in sterile production.
- Engages in general textile trading and markets branded apparel, diversifying revenue streams.
What Industry Does TYOBY Operate In?
Toyobo Co., Ltd. operates within the Basic Materials sector, specifically the Chemicals - Specialty industry, a segment characterized by innovation in material science and diverse application across numerous end-markets. This industry is driven by demand for advanced materials that offer enhanced performance, sustainability, and cost-efficiency. Toyobo's positioning is unique due to its broad diversification, encompassing high-performance films for electronics and packaging, functional polymers for industrial uses, specialized fibers for automotive and medical applications, and bio-products for healthcare. While the broader chemicals industry faces cyclical demand and raw material price volatility, the specialty chemicals segment, where Toyobo largely operates, often exhibits more stable growth due to proprietary formulations and niche applications. The competitive landscape includes large multinational chemical conglomerates and specialized material science firms. Toyobo differentiates itself through its extensive R&D, long history of innovation, and integrated manufacturing capabilities, allowing it to serve critical needs in high-growth sectors.
Who Are TYOBY's Key Customers?
- Electronics manufacturers requiring high-performance films for displays and optical components.
- Food and beverage companies needing advanced packaging films for preservation.
- Automotive industry suppliers utilizing specialized fibers for safety components and filters.
- Healthcare and pharmaceutical companies purchasing diagnostic enzymes, medical components, and contract manufacturing services.
- Industrial manufacturers seeking engineering plastics, adhesives, and protective coatings.
Forward Outlook
Wall Street analysts project Toyobo Co., Ltd. revenue of about $438.09B for fiscal 2026, with EPS near $103.12. The estimate reflects 4 contributing analysts.
Quarterly Financial Performance: Toyobo Co., Ltd.
Revenue for Toyobo Co., Ltd. came in at $111.83B during Q2 2026, a 3.7% contraction versus the preceding quarter. The company recorded net income of $3.11B, with diluted EPS of $35.52. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Basic Materials. Across the four most recent quarters, TYOBY averaged $36.51 in diluted EPS.
TYOBY Valuation & Market Position
With a $865M market cap, Toyobo Co., Ltd. sits in the small-cap segment of the market.
Key Financial Metrics
Return on equity for Toyobo Co., Ltd. stands at 6.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.0%, showing how much profit it generates from its asset base. TYOBY trades at a trailing price-to-earnings ratio of 11.41, below the Basic Materials sector average of ~22x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.67 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 8.8%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Toyobo Co., Ltd.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.46 places it in the distress zone, a signal of elevated financial risk.
Company Profile
Toyobo Co., Ltd. operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Osaka, JP. The company is led by CEO Ikuo Takeuchi. TYOBY has traded publicly since 1994.
TYOBY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Toyobo's future prospects, hinting at undervalued potential.
- Community sentiment indicates a growing belief in Toyobo's long-term strategy and market positioning.
- Positive narratives are circulating regarding Toyobo's innovative materials and potential applications in emerging industries.
- Market perception seems to be shifting towards recognizing Toyobo's intrinsic value, driven by increased media coverage and analyst attention.
Bear Case
- Insider selling, even if minor, can sometimes create uncertainty among investors about the company's near-term outlook.
- Negative social sentiment, stemming from concerns about competitive pressures, could dampen investor enthusiasm.
- Bearish community views highlight worries about Toyobo's ability to adapt to changing market dynamics and technological advancements.
- Market perception reflects some skepticism regarding Toyobo's growth prospects, especially compared to its peers in the materials sector.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $111.83B | $3.11B | $35.52 |
| Q1 2026 | $116.14B | $3.41B | $38.35 |
| Q4 2025 | $105.37B | $2.13B | $24.17 |
| Q3 2025 | $102.87B | $4.23B | $48.00 |
Based on FMP financials and quantitative analysis
TYOBY Latest News
No recent news available for TYOBY.
TYOBY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TYOBY.
Price Targets
Wall Street price target analysis for TYOBY.
TYOBY MoonshotScore
What does this score mean?
The MoonshotScore rates TYOBY 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Ikuo Takeuchi
CEO
Ikuo Takeuchi serves as the CEO of Toyobo Co., Ltd., overseeing a global workforce of 10,668 employees. His leadership is central to guiding the company's diverse operations across advanced materials, films, functional polymers, industrial materials, healthcare solutions, and textiles. While specific details on his prior career history and educational background are not provided in the source data, his role as CEO indicates significant experience in managing large-scale manufacturing and materials science enterprises within a global context.
Track Record: Under Ikuo Takeuchi's leadership, Toyobo Co., Ltd. continues to navigate the complexities of the advanced materials market, maintaining its diversified portfolio and operational footprint. His tenure is marked by the ongoing management of the company's extensive product lines, from high-performance films to critical medical components, ensuring the company's sustained presence in key industrial and healthcare sectors.
Toyobo Co., Ltd. ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate issued by a U.S. bank representing shares in a foreign stock. For TYOBY, a Level 1 ADR, it allows U.S. investors to trade shares of the Japanese company Toyobo Co., Ltd. on U.S. markets without directly buying shares on the Osaka exchange. This simplifies foreign investment by providing dollar-denominated trading and settlement.
- Home Market Ticker: Osaka Exchange, Japan
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: TYOB
TYOBY OTC Market Information
TYOBY trades on the OTC Other tier, which is the lowest of the three OTC Markets Group tiers (OTCQX, OTCQB, and OTC Pink, with OTC Other being a sub-tier of OTC Pink). Companies on OTC Other are not required to meet minimum financial standards or provide regular disclosures to OTC Markets Group. This contrasts sharply with major exchanges like NYSE or NASDAQ, which have strict listing requirements for market capitalization, share price, and financial reporting, ensuring greater transparency and investor protection.
- OTC Tier: OTC Other
- Limited liquidity and potentially wide bid-ask spreads due to OTC Other tier trading.
- Unknown disclosure status, leading to challenges in accessing timely and comprehensive financial information.
- Lack of stringent listing requirements compared to major exchanges, potentially higher risk.
- Increased difficulty in price discovery and valuation due to less transparent trading.
- Potential for less analyst coverage and institutional investor interest.
- Verify the company's financial reports and disclosures from its primary listing in Japan.
- Assess the company's business fundamentals, including revenue, profitability, and debt levels.
- Research the management team's track record and corporate governance practices.
- Evaluate the current trading volume and bid-ask spread to understand liquidity.
- Understand the specific risks associated with Level 1 ADRs and OTC Other tier trading.
- Monitor news and announcements from the company's home market.
- Consult with a financial advisor experienced in international and OTC investments.
- Established company history since 1882, indicating long-term operational stability.
- Global enterprise with a diversified portfolio of advanced materials and products.
- Primary listing on a recognized international exchange (Osaka Exchange).
- Known CEO, Ikuo Takeuchi, managing a significant employee base (10,668).
- Publicly available financial metrics (Market Cap, P/E, Margins, Dividend Yield).
What Investors Ask About Toyobo Co., Ltd. (TYOBY) — Basic Materials
What does Toyobo Co., Ltd. do?
Toyobo Co., Ltd. is a Japanese global enterprise, established in 1882, specializing in advanced materials and products across diverse sectors. Its core activities include manufacturing high-performance industrial films for electronics and packaging, such as PET films for displays and food preservation.
What are the key financial metrics investors watch for TYOBY?
For Toyobo Co., Ltd., investors typically monitor several key financial metrics to assess its performance within the Basic Materials sector. The Price-to-Earnings (P/E) ratio of 13.74 provides insight into how much investors are willing to pay for each dollar of earnings, offering a valuation perspective.
What are the main risks for TYOBY?
Toyobo Co., Ltd. faces several risks inherent to its operations and market position. As a specialty chemicals and materials company, it is susceptible to fluctuations in raw material costs, which can impact its profit margins. The company's global operations expose it to currency exchange rate risks, particularly between the Japanese Yen and the U.S.
What are the key factors to evaluate for TYOBY?
Evaluate TYOBY on fundamentals, analyst consensus, and risk factors. Toyobo Co., Ltd. presents a diversified investment profile rooted in its extensive portfolio of advanced materials and functional products, spanning films, polymers, textiles, and healthcare. Not financial advice.
How frequently does TYOBY data refresh on this page?
TYOBY's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven TYOBY's recent stock price performance?
Toyobo Co., Ltd. (TYOBY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product portfolio across films, polymers, fibers, and bio-products. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider TYOBY overvalued or undervalued right now?
Toyobo Co., Ltd. (TYOBY) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research TYOBY before investing?
Before investing in Toyobo Co., Ltd. (TYOBY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is derived solely from the provided source data. Market sizes and timelines for growth opportunities are not explicitly provided in the source and are inferred from market trends relevant to the company's products.
- Competitor information was not provided in the source data, hence the empty array.